We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-13.01%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.79B
AUM Growth
-$283M
Cap. Flow
-$93.2M
Cap. Flow %
-3.34%
Top 10 Hldgs %
67.96%
Holding
104
New
24
Increased
12
Reduced
21
Closed
21

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$20M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.2M
3
GM icon
General Motors
GM
+$9.45M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.46M
5
CCI icon
Crown Castle
CCI
+$7.4M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$21.4M
2
ACOR
Acorda Therapeutics
ACOR
+$12.8M
3
F icon
Ford
F
+$10.1M
4
TEX icon
Terex
TEX
+$9.24M
5
UAL icon
United Airlines
UAL
+$8.76M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.56%
2 Healthcare 22.3%
3 Financials 0.62%
4 Real Estate 0.57%
5 Materials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFFX
101
DELISTED
Affymetrix Inc
AFFX
– –
-1,200,000
Closed -$7.43M
ESV
102
CALL
DELISTED
Ensco Rowan plc
ESV
– –
-50,000
Closed -$10.8M
PGEM
103
DELISTED
Ply Gem Holdings, Inc.
PGEM
– –
-254,226
Closed -$3.55M
CIT
104
CALL
DELISTED
CIT Group Inc.
CIT
– –
-100,000
Closed -$4.88M
1 2 3 4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q4 2013 Portfolio in Review

As of Q4 2013, Artal Group held 104 positions worth $2.79B, down 9.2% from $3.07B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Artal Group withdrew a net $93.2M in Q4 2013, closing 21 positions and reducing 21 holdings. Its most notable exit was Ford, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Artal Group opened a new position in PHARMACYCLICS INC worth $17.5M.

  • Artal Group's largest Q4 2013 buy was PHARMACYCLICS INC: 165,000 shares worth $17.5M.
  • Artal Group added most to BioMarin Pharmaceuticals in Q4 2013, an estimated $10.2M increase.
  • Artal Group's biggest Q4 2013 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $21.4M.
  • Artal Group fully exited Ford in Q4 2013, selling an estimated $10.1M.
  • Artal Group's ten largest holdings make up 68% of its $2.79B portfolio in Q4 2013.
  • Artal Group opened 24 new positions and closed 21 in Q4 2013.
  • Artal Group's portfolio value fell 9.2% quarter-over-quarter to $2.79B.

Based on Artal Group's 13F filing for Q4 2013, filed 14 Feb 2014.